Panzura Introduces New Freedom Product Line CAMPBELL,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
60
Panzura Introduces New Freedom Product Line

CAMPBELL, CA--(Marketwired - Feb 15, 2017) -   Panzura ® today introduced its new Freedom product line, enabling organizations to combine the economics of cloud storage with the performance of flash to solve growing unstructured data challenges. The new Freedom product family -- Freedom Archive, Freedom NAS, and Freedom Collaboration -- frees organizations from storing unstructured data on expensive NAS systems and move, manage and access that data in any cloud. With Panzura's Freedom line, customers can choose the hybrid cloud storage functionality needed now and easily upgrade with a simple license to access additional functionality later. 

Panzura Freedom Archive eliminates the need to store less frequently accessed data on expensive primary or secondary storage from vendors like NetApp or EMC or transfer it to more traditional archiving methods such as tape or optical disk. Instead, Freedom Archive combines the benefits of high-performance local cache for high speed data ingest and on demand access to important data with the economics and limitless capacity of cloud storage to make archiving of petabytes of data dramatically simpler, faster and significantly less expensive.

Panzura's Freedom NAS provides organizations with fast performance to shared data and home directories by centralizing that data in the cloud while keeping active data cached close to the users and applications. Local users have full read-write abilities with the global namespace while users at offsite offices can read data from a central cloud repository. Freedom NAS is simpler, faster and less expensive than deploying separate primary, backup and archive storage at each site. 

Freedom Collaboration builds upon the benefits of Freedom Archive and Freedom NAS while providing full cross-site collaboration of project files regardless of where they are located. Global teams no longer need to wait for files to open or sync before receiving instant access to application data. Freedom Collaboration eliminates the need to maintain separate local copies of files and the version-control nightmares that can lead to data integrity issues. All files are read-write accessible at every site as though on a local, locking filer and all of the data is backed by a central cloud data repository.

"The rise of public cloud services has fundamentally altered the IT infrastructure landscape. The effects of this shift have disrupted few sectors more than the data storage segment. Faced with ever increasing capacity demands, the status quo of the traditional storage array is no longer sustainable for many organizations. Cloud can be an answer, but organizations still demand the performance of local storage," said Scott Sinclair, Senior Analyst at ESG. "Panzura's new Freedom product line enables organizations to take advantage of cloud economics, but not sacrifice fast, local performance all while choosing the level of functionality needed."

"Enterprises are accelerating their cloud first strategies. Combine this with the massive growth of unstructured data and the fact that 90% of that data has not been accessed in six months and you can see why enterprises are turning to hybrid cloud storage," said Patrick Harr, chief executive officer at Panzura. "Freedom Archive, Freedom NAS, and Freedom Collaboration enable enterprises to fulfill their cloud first initiatives, keep the fast flash local performance users and applications require, and save 70% compared to traditional storage." 

Availability and Pricing All three products in the Freedom product line are available immediately. Organizations can download a free, 30-day trial version of Freedom Archive at http://panzura.com/freedom-archive-download/ . Customers can also request a free trial license of Freedom NAS and Collaboration. Freedom products work across all major public cloud providers, including AWS, Microsoft Azure, Google, and IBM Cloud as well as private cloud object storage providers including IBM and EMC.

About Panzura Adding over two petabytes of enterprise storage under management per month, Panzura is a market leader in enterprise hybrid cloud storage. Panzura's hybrid cloud storage software seamlessly combines the economics, capacity, and business model of cloud storage with the flexibility, performance and features of enterprise storage. Using Panzura, enterprises shift from an antiquated storage status quo model into the cloud and unlock the power of data. Organizations like the Department of Justice, Milwaukee Tool, American College of Radiology and Chevon use Panzura for active archive, hybrid cloud NAS and cross-site collaboration. Please visit www.panzura.com for further information.

Follow us on Twitter: @PanzuraStorage Follow us on LinkedIn

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading